Literature DB >> 22193919

Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients.

Eva Pardina1, Roser Ferrer, Joaquín Rivero, Juan A Baena-Fustegueras, Albert Lecube, Jose M Fort, Víctor Vargas, Roberto Catalán, Julia Peinado-Onsurbe.   

Abstract

The objective of this study was to establish the relationship between the plasminogen activator inhibitor-1 (PAI-1), antithrombin-III (ATIII), fibrinogen, and white blood cell (WBC) levels in severely obese patients. We analyzed various plasma parameters implicated in the intrinsic and extrinsic coagulation pathway from 34 severely obese patients before and 1, 6, and 12 months after gastric bypass. In obese people, ATIII, fibrinogen, and WBC levels were in the upper limit of the normal range, and all were higher and significantly different from nonobese people. After bariatric surgery, the ATIII level continued to be high during the first month and increased until 12 months, while fibrinogen decreased only at that time. PAI-1 plasma protein and PAI-1 mRNA levels in liver and adipose tissue show similar profiles and had a strong positive correlation (r = 0.576, P = 0.0003 in liver; r = 0.433, P = 0.0004 in adipose tissue). They were higher in obese patients compared with nonobese control, but tended to recover normal values 1 month after surgery. Thus, the liver and adipose tissue could be an important source of PAI-1 protein in plasma. Gastric bypass surgery leads to a normalization of the hematological profile and a decrease in PAI-1 levels, which entails a decrease of risk for thromboembolism in severely obese.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22193919     DOI: 10.1038/oby.2011.361

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  5 in total

1.  Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls.

Authors:  Alison J Dawson; Thozhukat Sathyapalan; Peter Sedman; Ramzi Ajjan; Eric S Kilpatrick; Stephen L Atkin
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

Review 2.  More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity.

Authors:  Chunlan Zhang; Jingjing Zhang; Zhenqi Liu; Zhiguang Zhou
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

3.  Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery.

Authors:  E Pardina; R Ferrer; J Rossell; D Ricart-Jané; K A Méndez-Lara; J A Baena-Fustegueras; A Lecube; J Julve; J Peinado-Onsurbe
Journal:  Int J Obes (Lond)       Date:  2017-05-10       Impact factor: 5.095

4.  Risk of thrombosis and thromboembolic prophylaxis in obesity surgery: data analysis from the German Bariatric Surgery Registry.

Authors:  C Stroh; N Michel; D Luderer; S Wolff; V Lange; F Köckerling; C Knoll; T Manger
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

5.  The relationship between insulin sensitivity and serum antithrombin 3 activity in patients with type 2 diabetes.

Authors:  Hong Wang; Jie Cao; Jian-Bin Su; Xue-Qin Wang; Dong-Mei Zhang; Xiao-Hua Wang
Journal:  Endocr Connect       Date:  2021-06-23       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.